242 related articles for article (PubMed ID: 32976906)
1. Nanocarriers for effective nutraceutical delivery to the brain.
Meenambal R; Srinivas Bharath MM
Neurochem Int; 2020 Nov; 140():104851. PubMed ID: 32976906
[TBL] [Abstract][Full Text] [Related]
2. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
Md S; Mustafa G; Baboota S; Ali J
Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
Nair KGS; Ramaiyan V; Sukumaran SK
Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
5. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
Varghese NM; Senthil V; Saxena SK
J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood-brain barrier into brain.
Dutta L; Mukherjee B; Chakraborty T; Das MK; Mondal L; Bhattacharya S; Gaonkar RH; Debnath MC
Drug Deliv; 2018 Nov; 25(1):504-516. PubMed ID: 29426257
[TBL] [Abstract][Full Text] [Related]
10. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
12. Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions.
Sandhir R; Yadav A; Sunkaria A; Singhal N
Neurochem Int; 2015 Oct; 89():209-26. PubMed ID: 26315960
[TBL] [Abstract][Full Text] [Related]
13. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
14. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
15. Current Strategies for Brain Drug Delivery.
Dong X
Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases.
Behl T; Kaur G; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Zengin G; Bungau SG; Munteanu MA; Brisc MC; Andronie-Cioara FL; Brisc C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919895
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
Gastaldi L; Battaglia L; Peira E; Chirio D; Muntoni E; Solazzi I; Gallarate M; Dosio F
Eur J Pharm Biopharm; 2014 Aug; 87(3):433-44. PubMed ID: 24833004
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
Gao H
J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
[TBL] [Abstract][Full Text] [Related]
19. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery to the brain using magnetic nanoparticles.
Thomsen LB; Thomsen MS; Moos T
Ther Deliv; 2015; 6(10):1145-55. PubMed ID: 26446407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]